EPO906 Therapy in Patients With Advanced Colorectal Cancer

NCT00035087 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms
Colonic Neoplasms

Interventions

DRUG: epothilone b

Sponsor

Novartis Pharmaceuticals